RE:RE:Hey Muttley!MuttleyKnows wrote: So the company had 8.2 million usd in revenue in Q3. This number already reflects the weakness in the entire cannabis sector post Covid lockdowns. The other downside hit to revenue for this quarter would be sale of the Oregon assets. This impact will be small.
Thus it boils down to how quickly they have been selling their new organic growth inventory and whether they have sold it externally or kept it for internal use. If kept most for internal use then revenue won't ramp as quickly but margins and cash flow will be much better.
Personally I think we will get the trifecta this quarter. Revenue will be over 10 million along with better margins and more free cash flow. Just my opinion so we will see.
I hope you are right and the triecta is soon followed by passage of the SAFE Act in April (quadfecta?)
That will lift all boats in the sector and create a nice run across the board IMO.
Whether that run continues throughout 2022 depends much upon whether the Dems and or the Republicans want to buy mid-term election votes on the issue of legalization federally.
My suspiciion is Yes, someone will raise it and or put it into their platform. So could CXXI pop up over $ 1? Easily. If the sector catches fire, then likely it goes much further. New money first goes to tthe majors and non-cash burners.
Buy some and grab a bowl of popcorn, or sleep well , comfortable in the knowledge that, without US legalization talk, they are making money, reducing debt, generating postive cash flow, and...eventually.... one-day will get the big lift (buyout or ride the legalization spike).
No brainer IMO
MM